针对Foxp3的翻译后修改:对于调控性T细胞特异性治疗的新范式
Farooq Riaz1, Zhihui Huang1, Fan Pan1
1Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, China.
Frontiers in immunology
|November 8, 2023
概括
准Foxp3+调节性T (Treg) 细胞对于抗瘤免疫是至关重要的. 调节Foxp3后翻译修饰 (PTMs) 是一种有希望的治疗策略,用于控制瘤微环境 (TME) 中的Treg功能.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 瘤微环境 (TME) 抑制抗瘤免疫力,促进癌症的进展.
- 福克斯p3+调节T (Treg) 细胞是TME中的关键免疫抑制参与者.
- 目前的Treg向疗法具有系统性影响和自身免疫性疾病的风险.
研究的目的:
- 审查Tregs在癌症中的免疫抑制机制.
- 探索 Foxp3 后翻译修饰 (PTM) 在 Treg 功能中的作用.
- 确定Treg调节在TME中的潜在治疗点和策略.
主要方法:
- 对Treg细胞,Foxp3,PTM和癌症免疫学研究的文献综述.
- 对针对Tregs及其PTMs的治疗策略的研究分析.
- 综合目前对Treg介导免疫抑制和Foxp3调节的理解.
主要成果:
- 福克斯p3 PTMs (乙化,糖化,化,无处不在化,甲基化) 显著影响福克斯p3活性,Treg稳定性和免疫抑制功能.
- 针对参与Foxp3 PTMs的向酶可以调节Treg活性.
- 对Foxp3 PTMs的药理定位是一个潜在的策略,可以增强抗瘤免疫力,同时减轻系统性自身免疫风险.
结论:
- 了解Foxp3 PTM对于开发新型癌症免疫疗法至关重要.
- 调节Foxp3 PTMs为Treg向治疗提供了一个比Treg耗尽更细致的方法.
- 本综述强调了通过Foxp3 PTMs准Treg功能来改善抗瘤免疫力的治疗途径.
相关概念视频
01:24Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
02:23Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K